NIA Application Information

NIA T32 Application Information

The Neuroscience of Aging training program is open to Ph.D. and M.D./Ph.D. students and post-doctoral trainees. 

Graduate student appointments are considered after the student has matriculated to OHSU and for year 2 and/or beyond of the graduate studies.  

To apply for a slot on the NIA-funded T32, please share the following information with Jacob Raber (raberj@ohsu.edu) and Henryk Urbanski (urbanski@ohsu.edu), Program Directors on this training program: 

 Trainee letter containing: 

  1. interest of trainee in aging and AD research. 
  2. short- and long-term career goals. 
  3. CV 
  4. current funding for trainee and date of expiration of that funding. 
  5. in case of a post-doc application, total years of previous support on T32s and NRSAs. This one is needed as there are NIH limitation about how many years a trainee can receive training support; three years for post-doctoral trainees. 

 Letters of support: 

  1. letters of support of the mentor(s) and two additional letters of support.

Requesting a Second Year on the NIA T32

Trainees on the NIA T32 can apply for slot for a second year on the NIA T32, provided that they would be allowed to receive such support according to NIH guidelines. In the request to Jacob Raber and Henryk Urbanski, please describe the progress made in aging-related research over the last year, progress made in non-aging related research, and plans for aging-related and non-aging related research in the upcoming year and include a CV. 

Please note that the training grant slots on the T32 are limited (5 pre-doc slots and 3 post-doc slots) and second year slots are not automatically awarded but awarded on a competitive basis. Provided slots are available in a given year, members of the executive committee will review the applications and for the limited training slots that are available on a competitive basis, priority will be given to trainees that have neuroscience of aging, and especially neurodegenerative diseases and Alzheimer’s disease, as their primary research focus.